The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

In a recent article in the journal Antioxidants, researchers in Germany investigated whether cardiovascular drugs such as ...

Erri, S. and Oroszi, T. (2025) Isolated Systolic Hypertension in Geriatrics. International Journal of Clinical Medicine, 16, ...

The researchers found that people taking alpha-1 blockers – terazosin, doxazosin, and alfuzosin – were around 40% less likely to develop DLB than people taking other prostate drugs ...

The Food and Drug Administration (FDA ... at least 45 years old with OAB on BPH pharmacological therapy (eg, alpha blocker monotherapy or in combination with a 5-alpha reductase inhibitor).

Liver disease and oncology divisions have slightly underperformed but show potential for growth, especially with new acquisitions and upcoming drug approvals ... an HIV-1 integrase blocker ...

The alpha blocker is typically prescribed to manage a nuisance symptom. Here's why the FDA says patients and healthcare ...

As ever, the top product candidate being developed by INMB is the dominant-negative form of tumor necrosis factor-alpha (TNFa ... that treatment with blockers of TNF signaling, which are used ...

Testosterone blockers ... Finasteride is a drug widely used to treat male-pattern hair loss (under the brand name Propecia) and enlarged prostate (under the brand name Proscar). Finasteride belongs to ...

Immune-histologically, IH cells are exclusively glucose transporter protein-1 positive.The ... and topical beta blockers as an effective treatment option resulted in a rapid shift away from systemic ...

Table 1 shows patient data including the type of α 1-blocker taken and other baseline ... Five patients had hypertension with anti-hypertension drugs, three had diabetes mellitus with anti ...